These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15015070)

  • 21. Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook.
    Vester U; Kranz B; Zimmermann S; Hoyer PF
    Pediatr Nephrol; 2003 Jul; 18(7):661-4. PubMed ID: 12750975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome.
    Elhence R; Gulati S; Kher V; Gupta A; Sharma RK
    Pediatr Nephrol; 1994 Feb; 8(1):1-3. PubMed ID: 8142205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA; Esezobor CI; Lesi FE
    Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
    Ekka BK; Bagga A; Srivastava RN
    Pediatr Nephrol; 1997 Oct; 11(5):597-9. PubMed ID: 9323286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous pulse cyclophosphamide--is it effective in children with steroid-resistant nephrotic syndrome?
    Alshaya HO; Al-Maghrabi JA; Kari JA
    Pediatr Nephrol; 2003 Nov; 18(11):1143-6. PubMed ID: 13680329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
    Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
    Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J; Ehrich JH; Querfeld U
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
    Besbas N; Topaloglu R; Saatci O; Bakkaloglu A
    Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclophosphamide in the treatment of idiopathic nephrotic syndrome.
    Pennisi AJ; Grushkin CM; Lieberman E
    Pediatrics; 1976 Jun; 57(6):948-51. PubMed ID: 934751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome.
    Mantan M; Sriram CS; Hari P; Dinda A; Bagga A
    Pediatr Nephrol; 2008 Sep; 23(9):1495-502. PubMed ID: 18566839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children.
    Donia AF; Gazareen SH; Ahmed HA; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
    Nephrol Dial Transplant; 2003 Oct; 18(10):2054-8. PubMed ID: 13679480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome.
    Zagury A; de Oliveira AL; de Moraes CA; de Araujo Montalvão JA; Novaes RH; de Sá VM; Monteiro de Carvalho Dde B; Matuck T
    Pediatr Nephrol; 2011 Jun; 26(6):915-20. PubMed ID: 21399901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steroid resistant nephrotic syndrome is sustained remission attainable.
    Nammalwar BR; Vijaykumar M; Prahlad N; Jain DV
    Indian Pediatr; 2006 Jan; 43(1):39-43. PubMed ID: 16465005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
    Hafeez F; Ahmad TM; Anwar S
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remission of infantile systemic lupus erythematosus with intravenous cyclophosphamide.
    Saberi MS; Jones BA
    Pediatr Nephrol; 1998 Feb; 12(2):136-8. PubMed ID: 9543373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management Of Childhood Steroid Dependent Nephrotic Syndrome With Cyclophosphamide - An Experience At Ayub Teaching Hospital, Abbottabad.
    Hussain Shah SS; Aalia B; Raza A; Najeeb S; Rehman AU
    J Ayub Med Coll Abbottabad; 2021; 33(2):213-216. PubMed ID: 34137531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.